The manufacturer of a breast cancer drug which has been deemed "too expensive" to be offered by the NHS has hit back at the decision.
Dr Jayson Dallas, general manager of Roche Products Limited, declared it "an incredible injustice."
Despite Roche offering a significant discount, we are once again disappointed that Nice has not shown any flexibility on access to Kadcyla.
Refusing patients access to this drug is an incredible injustice and tantamount to turning the clock back in cancer research and development. We plan to appeal this decision.
More top news
Tom Bradby will play host to the leaders of the three main parties, as well as the biggest names from the worlds of arts and culture.
One of the greatest sporting events on earth gets underway this week as the Ryder Cup heads to Scotland, here's everything you need to know
A toddler was in need of an unusual rescue after she got a kettle stuck on her head while playing at home in Chile.